cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Qing-Rong Chen(National Cancer Institute), Javed Khan(Kent State University), Sven Bilke(Illumina (United States)), Jun S. Wei(Center for Cancer Research), Frank Berthold(University of Cologne), Craig C. Whiteford(National Cancer Institute), Nicola Cenacchi(National Cancer Institute), Chang‐Gue Son(Daejeon University), Braden T. Greer(National Cancer Institute), Alexei L. Krasnoselsky(National Cancer Institute), Daniel Catchpoole(Children's Hospital at Westmead), Manfred Schwab(German Cancer Research Center), Frank Westermann(German Cancer Research Center)
Cited by 90
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k